{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:06:28Z","timestamp":1762459588408},"reference-count":63,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pmbts.2018.04.004","type":"book-chapter","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T13:47:45Z","timestamp":1527601665000},"page":"255-272","source":"Crossref","is-referenced-by-count":17,"title":["Using Epigenetic Tools to Investigate Antidepressant Response"],"prefix":"10.1016","author":[{"given":"Laura M.","family":"Fiori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rixing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsey","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Belzeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9820","key":"10.1016\/bs.pmbts.2018.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","article-title":"Major depressive disorder: new clinical, neurobiological, and treatment perspectives","volume":"379","author":"Kupfer","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.04.004_bb0015","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2013.00146","article-title":"Mechanisms of antidepressant resistance","volume":"4","author":"El-Hage","year":"2013","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0035","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH","year":"2016"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.04.004_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/pgs.15.5","article-title":"Genome-wide association studies in pharmacogenomics of antidepressants","volume":"16","author":"Lin","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nn.2270","article-title":"Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse","volume":"12","author":"McGowan","year":"2009","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.04.004_bb0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epigenetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.04.004_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.04.004_bb0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbamcr.2010.06.013","article-title":"MicroRNAs: synthesis, mechanism, function, and recent clinical trials","volume":"1803","author":"Wahid","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.04.004_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn3879","article-title":"Determining the role of microRNAs in psychiatric disorders","volume":"16","author":"Issler","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.04.004_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4939-7514-3_12","article-title":"A bloody primer: analysis of RNA-seq from tissue admixtures","volume":"1712","author":"Shannon","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2164-13-28","article-title":"Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA","volume":"13","author":"Mastrokolias","year":"2012","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.04.004_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jmoldx.2015.11.004","article-title":"Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development","volume":"18","author":"Margolin","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fmolb.2015.00013","article-title":"Methylation of cell-free circulating DNA in the diagnosis of cancer","volume":"2","author":"Warton","year":"2015","journal-title":"Front Mol Biosci"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0100","doi-asserted-by":"crossref","first-page":"34468","DOI":"10.18632\/oncotarget.16519","article-title":"A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0105","doi-asserted-by":"crossref","first-page":"45807","DOI":"10.18632\/oncotarget.17416","article-title":"Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0110","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3892\/ol.2017.5569","article-title":"Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer","volume":"13","author":"Dejima","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13148-017-0343-5","article-title":"Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 diabetes: a review and future prospect","volume":"9","author":"Zhang","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"13","key":"10.1016\/bs.pmbts.2018.04.004_bb0120","doi-asserted-by":"crossref","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13054-016-1578-9","article-title":"The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review","volume":"21","author":"Gogenur","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360802485875","article-title":"Clinical use of circulating nucleosomes","volume":"46","author":"Holdenrieder","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12920-015-0109-x","article-title":"Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing","volume":"8","author":"Lopez","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.04.004_bb0140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/nn.3816","article-title":"Analytical tools and current challenges in the modern era of neuroepigenomics","volume":"17","author":"Maze","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ijnp\/pyx034","article-title":"Investigation of miR-1202, miR-135a, and miR-16 in major depressive disorder and antidepressant response","volume":"20","author":"Fiori","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.04.004_bb0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nm.3582","article-title":"miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment","volume":"20","author":"Lopez","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0155","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/npp.2017.9","article-title":"Co-variation of peripheral levels of miR-1202 and brain activity and connectivity during antidepressant treatment","volume":"42","author":"Lopez","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0160","doi-asserted-by":"crossref","first-page":"15497","DOI":"10.1038\/ncomms15497","article-title":"MicroRNAs 146a\/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK\/Wnt-system genes","volume":"8","author":"Lopez","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpsychires.2016.03.015","article-title":"Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder","volume":"78","author":"He","year":"2016","journal-title":"J Psychiatr Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.04.004_bb0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neuron.2014.05.042","article-title":"MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity","volume":"83","author":"Issler","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.112","article-title":"Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode","volume":"2","author":"Belzeaux","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033201","article-title":"MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects","volume":"7","author":"Smalheiser","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1461145713000941","article-title":"Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers","volume":"17","author":"Lopez","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086469","article-title":"Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects","volume":"9","author":"Smalheiser","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpsychires.2014.08.007","article-title":"Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients","volume":"59","author":"Fan","year":"2014","journal-title":"J Psychiatr Res"},{"issue":"5998","key":"10.1016\/bs.pmbts.2018.04.004_bb0205","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1193692","article-title":"miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants","volume":"329","author":"Baudry","year":"2010","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2015.02.022","article-title":"CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system","volume":"178","author":"Song","year":"2015","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.04.004_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075960","article-title":"Chronic academic stress increases a group of microRNAs in peripheral blood","volume":"8","author":"Honda","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.04.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046921","article-title":"Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life","volume":"7","author":"Bai","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2015.11.013","article-title":"Time-dependent miR-16 serum fluctuations together with reciprocal changes in the expression level of miR-16 in mesocortical circuit contribute to stress resilient phenotype in chronic mild stress\u2014an animal model of depression","volume":"26","author":"Zurawek","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.04.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073385","article-title":"Acute stress alters amygdala microRNA miR-135a and miR-124 expression: inferences for corticosteroid dependent stress response","volume":"8","author":"Mannironi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0235","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1007\/s12035-016-0107-9","article-title":"Reciprocal microRNA expression in mesocortical circuit and its interplay with serotonin transporter define resilient rats in the chronic mild stress","volume":"54","author":"Zurawek","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.04.004_bb0240","first-page":"1142","article-title":"Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population","volume":"6","author":"He","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.04.004_bb0250","doi-asserted-by":"crossref","first-page":"pyv025","DOI":"10.1093\/ijnp\/pyv025","article-title":"Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment","volume":"18","author":"Zhang","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.04.004_bb0255","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/mp.2015.91","article-title":"Sex differences in glutamate receptor gene expression in major depression and suicide","volume":"20","author":"Gray","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.04.004_bb0260","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2016.138","article-title":"Dysregulation of the glutamatergic receptors after antidepressant treatment in human neural progenitor cells","volume":"22","author":"Cruceanu","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.04.004_bb0265","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0270","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2012.07.038","article-title":"Role of mGluR4 in acquisition of fear learning and memory","volume":"66","author":"Davis","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0275","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jad.2016.10.008","article-title":"A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder","volume":"208","author":"Dadkhah","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/bs.pmbts.2018.04.004_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2015.08.038","article-title":"MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4","volume":"606","author":"Li","year":"2015","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.04.004_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-7-13","article-title":"Childhood abuse is associated with methylation of multiple loci in adult DNA","volume":"7","author":"Suderman","year":"2014","journal-title":"BMC Med Genomics"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.04.004_bb0290","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archgenpsychiatry.2011.2287","article-title":"Genome-wide epigenetic regulation by early-life trauma","volume":"69","author":"Labont\u00e9","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119061","article-title":"DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls","volume":"10","author":"Booij","year":"2015","journal-title":"PLos One"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.04.004_bb0300","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S146114571400039X","article-title":"Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response","volume":"17","author":"Domschke","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.04.004_bb0305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/mp.2013.58","article-title":"Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression","volume":"19","author":"Tadic","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.04.004_bb0310","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.biopsych.2012.07.009","article-title":"Epigenetic modulation of BDNF gene in patients with major depressive disorder","volume":"73","author":"D'Addario","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.04.004_bb0315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mp.2012.38","article-title":"Epigenetic regulation of BDNF expression according to antidepressant response","volume":"18","author":"Lopez","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"16","key":"10.1016\/bs.pmbts.2018.04.004_bb0320","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jpsychires.2010.04.011","article-title":"Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression","volume":"44","author":"Belzeaux","year":"2010","journal-title":"J Psychiatr Res"}],"container-title":["Progress in Molecular Biology and Translational Science","Neuroepigenetics and Mental Illness"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318300711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318300711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T19:47:12Z","timestamp":1604346432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117318300711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":63,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2018.04.004","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}